优化Rituximab疗法与推疗法对异常病性膜性病:一个单中心的回顾性队列研究
Peng Yan1, Xiangdong Fang1, Ben Ke1
1Department of Nephrology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
International immunopharmacology
|February 20, 2024
概括
一种低剂量,长期的rituximab (RTX) 疗法显示了与标准剂量可比的疗效,用于异形膜性病 (IMN). 这种优化的RTX方法显著降低了感染风险,特别是在老年患者中.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 异形膜性病 (IMN) 是成年人性综合征的主要原因.
- 利图西马布 (RTX) 是IMN的第一线疗法,比传统治疗提供更好的安全性.
- 在IMN中RTX的最佳剂量方案需要进一步调查.
研究的目的:
- 为了比较循环皮质类固醇-cyclophosphamide治疗方案的临床疗效和安全性,与IMN的两个不同的RTX剂量策略进行比较.
- 评估每种治疗方案相关的缓解率和不良事件.
- 确定影响治疗结果和不良事件的潜在因素.
主要方法:
- 一项涉及58名IMN患者的研究通过脏活检证实.
- 三组治疗:循环疗法 (n=20),优化RTX (500毫克/周,总量2000毫克,n=22) 和推的RTX (1000毫克在第1天和第15天,n=16).
- 9个月后完全缓解 (CR),部分缓解 (PR) 和不良事件 (类固醇糖尿病,感染,白血病) 的比较.
主要成果:
- 在9个月后,在三个组中没有观察到复合缓解 (CR+PR) 或CR率的显著差异.
- 循环疗法组的类固醇糖尿病发病率较高 (35%).
- 与推的RTX相比,优化的RTX疗法显著降低了感染率 (9.1%与37.5%,P=0.049),特别是在60岁以上的患者中 (P=0.026).
- 较低的抗PLA2R基线水平与更高的感染风险相关 (P=0.043).
结论:
- 低剂量,长时间的RTX疗法在疗效方面与IMN的标准推疗法相比并非劣.
- 优化的RTX疗法有效降低IMN患者感染的发生率.
- 对于IMN的老年患者,建议使用低剂量,长期的RTX治疗.
更多相关视频
12:36Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
Published on: June 26, 2018
9.5K
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
414
相关概念视频
Cardiomyopathy IV: Restrictive Cardiomyopathy
952
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
Nephrotic Syndrome II : Assessment and Medical Management
409
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
409
